Annual EBITDA:
-$13.99M+$9.74M(+41.04%)Summary
- As of today, XERS annual EBITDA is -$13.99 million, with the most recent change of +$9.74 million (+41.04%) on December 31, 2024.
- During the last 3 years, XERS annual EBITDA has risen by +$99.67 million (+87.69%).
- XERS annual EBITDA is now -6.90% below its all-time high of -$13.09 million, reached on December 31, 2016.
Performance
XERS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$9.92M+$2.27M(+29.74%)Summary
- As of today, XERS quarterly EBITDA is $9.92 million, with the most recent change of +$2.27 million (+29.74%) on September 30, 2025.
- Over the past year, XERS quarterly EBITDA has increased by +$19.69 million (+201.55%).
- XERS quarterly EBITDA is now at all-time high.
Performance
XERS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$22.43M+$19.69M(+718.05%)Summary
- As of today, XERS TTM EBITDA is $22.43 million, with the most recent change of +$19.69 million (+718.05%) on September 30, 2025.
- Over the past year, XERS TTM EBITDA has increased by +$54.85 million (+169.20%).
- XERS TTM EBITDA is now at all-time high.
Performance
XERS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
XERS EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +41.0% | +201.6% | +169.2% |
| 3Y3 Years | +87.7% | +163.5% | +123.8% |
| 5Y5 Years | +88.1% | +179.0% | +123.7% |
XERS EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +87.7% | at high | +163.5% | at high | +123.8% |
| 5Y | 5-Year | at high | +88.1% | at high | +126.1% | at high | +120.0% |
| All-Time | All-Time | -6.9% | +88.1% | at high | +126.1% | at high | +118.1% |
XERS EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $9.92M(+29.7%) | $22.43M(+718.1%) |
| Jun 2025 | - | $7.65M(>+9900.0%) | $2.74M(+127.6%) |
| Mar 2025 | - | $53.00K(-98.9%) | -$9.94M(+52.7%) |
| Dec 2024 | -$13.99M(+41.0%) | $4.81M(+149.3%) | -$21.02M(+35.2%) |
| Sep 2024 | - | -$9.77M(-94.1%) | -$32.41M(-33.9%) |
| Jun 2024 | - | -$5.03M(+54.4%) | -$24.20M(+23.9%) |
| Mar 2024 | - | -$11.03M(-67.6%) | -$31.79M(-3.0%) |
| Dec 2023 | -$23.73M(+65.8%) | -$6.58M(-323.0%) | -$30.85M(+14.2%) |
| Sep 2023 | - | -$1.56M(+87.7%) | -$35.94M(+28.1%) |
| Jun 2023 | - | -$12.62M(-25.0%) | -$50.01M(+6.1%) |
| Mar 2023 | - | -$10.10M(+13.5%) | -$53.25M(+21.4%) |
| Dec 2022 | -$69.31M(+39.0%) | -$11.67M(+25.4%) | -$67.78M(+28.0%) |
| Sep 2022 | - | -$15.63M(+1.4%) | -$94.09M(+8.2%) |
| Jun 2022 | - | -$15.85M(+35.6%) | -$102.49M(+8.4%) |
| Mar 2022 | - | -$24.63M(+35.1%) | -$111.90M(-8.2%) |
| Dec 2021 | -$113.67M | -$37.97M(-58.0%) | -$103.38M(-24.0%) |
| Sep 2021 | - | -$24.04M(+4.9%) | -$83.40M(-16.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$25.27M(-56.9%) | -$71.93M(-4.9%) |
| Mar 2021 | - | -$16.10M(+10.5%) | -$68.55M(+14.7%) |
| Dec 2020 | -$79.12M(+32.8%) | -$18.00M(-43.3%) | -$80.38M(+15.2%) |
| Sep 2020 | - | -$12.56M(+42.6%) | -$94.80M(+15.3%) |
| Jun 2020 | - | -$21.89M(+21.6%) | -$111.98M(+9.6%) |
| Mar 2020 | - | -$27.93M(+13.8%) | -$123.93M(-2.2%) |
| Dec 2019 | -$117.80M(-105.9%) | -$32.42M(-9.0%) | -$121.30M(-11.3%) |
| Sep 2019 | - | -$29.74M(+12.1%) | -$109.02M(-15.7%) |
| Jun 2019 | - | -$33.84M(-33.7%) | -$94.22M(-29.7%) |
| Mar 2019 | - | -$25.30M(-25.6%) | -$72.66M(-23.1%) |
| Dec 2018 | -$57.22M(-117.3%) | -$20.14M(-34.8%) | -$59.02M(-51.8%) |
| Sep 2018 | - | -$14.94M(-21.7%) | -$38.88M(-23.4%) |
| Jun 2018 | - | -$12.28M(-5.2%) | -$31.52M(-63.8%) |
| Mar 2018 | - | -$11.67M(-54.1%) | -$19.24M(-57.9%) |
| Dec 2017 | -$26.33M(-101.1%) | - | - |
| Sep 2017 | - | -$7.57M(-64.2%) | -$12.18M(-164.2%) |
| Mar 2017 | - | -$4.61M | -$4.61M |
| Dec 2016 | -$13.09M | - | - |
FAQ
- What is Xeris Biopharma Holdings, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. annual EBITDA year-on-year change?
- What is Xeris Biopharma Holdings, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. quarterly EBITDA year-on-year change?
- What is Xeris Biopharma Holdings, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. TTM EBITDA year-on-year change?
What is Xeris Biopharma Holdings, Inc. annual EBITDA?
The current annual EBITDA of XERS is -$13.99M
What is the all-time high annual EBITDA for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high annual EBITDA is -$13.09M
What is Xeris Biopharma Holdings, Inc. annual EBITDA year-on-year change?
Over the past year, XERS annual EBITDA has changed by +$9.74M (+41.04%)
What is Xeris Biopharma Holdings, Inc. quarterly EBITDA?
The current quarterly EBITDA of XERS is $9.92M
What is the all-time high quarterly EBITDA for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high quarterly EBITDA is $9.92M
What is Xeris Biopharma Holdings, Inc. quarterly EBITDA year-on-year change?
Over the past year, XERS quarterly EBITDA has changed by +$19.69M (+201.55%)
What is Xeris Biopharma Holdings, Inc. TTM EBITDA?
The current TTM EBITDA of XERS is $22.43M
What is the all-time high TTM EBITDA for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high TTM EBITDA is $22.43M
What is Xeris Biopharma Holdings, Inc. TTM EBITDA year-on-year change?
Over the past year, XERS TTM EBITDA has changed by +$54.85M (+169.20%)